The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart Failure
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the hypothesis that treatment with oral ALT-711 twice
daily for 16 weeks will improve aortic distensibility, exercise tolerance, and quality of
life in elderly patients with isolated diastolic heart failure (DHF), and that the
improvements in exercise tolerance will correlate with the improvements in aortic
distensibility.